Submission for OMB Review; 30-Day Comment Request; Population Assessment of Tobacco and Health (PATH) Study-3rd Wave (NIDA), 34684-34685 [2015-14902]
Download as PDF
<![CDATA[
34684
Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices
Title X Family Planning Program
[‘‘Population Research and Voluntary
Family Planning Programs’’ (91)], which
was enacted in 1970 as Title X of the
Public Health Service Act (Section 1001
of Title X of the Public Health Service
Act, 42 United States Code [U.S.C.]
300).
resources to Title X centers. Data will be
collected through an online data
collection tool directly from grantees
and from Title X centers.
Likely Respondents: This annual
reporting requirement is service sites
that receive funding (either directly
from OPA or through a sub recipient or
grantee agency) for family planning
services authorized and funded by the
long term sustainability of the Title X
network.
Data collected from this effort will be
used to inform the work of the training
centers so they can better support the
Title X grantees. This data will help
OPA better understand challenges
affecting Title X centers in order to
better work with HHS entities and
national stakeholders to provide
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
responses per
respondent
Number of
respondents
Average
annualized
burden per
response
(hours)
Annual
total burden
(hours)
Type of respondent
Form name
Grantees ........................
Service Sites ..................
Sustainability Assessment—Grantees ................
Sustainability Assessment—Sites .......................
92
4,168
1
1
0.66
0.66
60.72
2750.88
Total ........................
..............................................................................
4,260
........................
........................
2,811.60
Terry S. Clark,
Asst Information Collection Clearance
Officer.
[FR Doc. 2015–14850 Filed 6–16–15; 8:45 am]
BILLING CODE 4150–48–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Population
Assessment of Tobacco and Health
(PATH) Study—3rd Wave (NIDA)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on February 11,
2015, pages 7619–7620 and allowed 60days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Institute on Drug Abuse (NIDA),
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
(PATH) Study—Third Wave of Data
Collection—0925–0664—Revision,
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH), in partnership with the Food and
Drug Administration (FDA).
Need and Use of Information
Collection: This is a revision request
(OMB 0925–0664, expires 9/30/2016)
for the Population Assessment of
Tobacco and Health (PATH) Study to
conduct the third wave of data
collection. The PATH Study is a
national longitudinal cohort study of
tobacco use behavior and health among
the U.S. household population of adults
age 18 and older and youth ages 12 to
17. The Study conducts annual
interviews and collects biospecimens
from adults to assess within-person
changes and between-person differences
in tobacco-product use behaviors and
related health conditions over time. Its
longitudinal, population-based data will
help to enhance the evidence base that
informs FDA’s regulatory actions under
the Family Smoking Prevention and
Control Act to protect the Nation’s
public health and reduce its burden of
tobacco-related morbidity and mortality.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
54,434.
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_Submission@
omb.eop.gov or by fax to (202) 395–
6974, Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project,
contact: Dr. Kevin P. Conway, Deputy
Director, Division of Epidemiology,
Services, and Prevention Research,
NIDA, NIH, 6001 Executive Boulevard,
Room 5185, Rockville, MD 20852; or
call non-toll-free number (301) 443–
8755 or Email your request, including
your address to: PATHprojectofficer@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Population
Assessment of Tobacco and Health
ESTIMATED ANNUALIZED BURDEN HOURS
Form or activity name
Type of
respondent
Adult Extended Interview .......................................................
Consent for Adult Extended Interview ...................................
Adults ..........
Adults ..........
VerDate Sep<11>2014
18:47 Jun 16, 2015
Jkt 235001
PO 00000
Frm 00079
Fmt 4703
Number of
respondents
Sfmt 4703
Number of
responses per
respondent
25,444
2,046
E:\FR\FM\17JNN1.SGM
1
1
17JNN1
Average
burden per
response
(in hours)
1
4/60
Total annual
burden hours
25,444
136
34685
Federal Register / Vol. 80, No. 116 / Wednesday, June 17, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form or activity name
Type of
respondent
Adult Extended Interview (Aged-up) ......................................
Consent for Biological Samples .............................................
Biospecimen Collection: Urine ...............................................
Biospecimen Collection: Blood ...............................................
Tobacco Use Form .................................................................
Follow-up/Tracking Participant Information Form for Adults ..
Youth Extended Interview ......................................................
Assent for Youth Extended Interview .....................................
Youth Extended Interview (Aged-up) .....................................
Parent Interview .....................................................................
Parent Permission and Consent for Parent Interview ...........
Parent Interview (Aged-up) ....................................................
Verification Interview ..............................................................
Validation Interview ................................................................
Follow-up/Tracking Participant Information Form for Youth ..
Follow-up/Tracking Participant Information Form for Sample
Shadow Youth.
Adults ..........
Adults ..........
Adults ..........
Adults ..........
Adults ..........
Adults ..........
Youth ...........
Youth ...........
Youth ...........
Parents ........
Parents ........
Parents ........
Adults ..........
Adults ..........
Parents ........
Parents ........
Dated: June 12, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015–14902 Filed 6–16–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Neurobiology of Psychiatric
Disorders and Addictions.
Date: June 24, 2015.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Sep<11>2014
18:47 Jun 16, 2015
Jkt 235001
Number of
respondents
1,780
1,780
13,805
765
14,570
27,224
9,625
1,923
1,923
9,818
2,161
1,961
35,564
3,579
11,548
2,282
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Non HIV Microbial Vaccines and
Countermeasures.
Date: July 13–14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 E. Wacker Drive, Chicago, IL
60601375.
Contact Person: Andrea Keane-Myers, BS,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
Bethesda, MD 20892, 3014351221,
andrea.keane-myers@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Oncological Sciences.
Date: July 13–14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ola Mae Zack Howard,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 4192, MSC
7806, Bethesda, MD 20892, 301–451–4467,
howardz@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Vascular Regulation and Diseases.
Date: July 16–17, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
1
2
1
1
1
1
1
1
1
1
2
2
Average
burden per
response
(in hours)
68/60
5/60
10/60
18/60
5/60
8/60
35/60
3/60
45/60
16/60
5/60
19/60
2/60
4/60
8/60
8/60
Total annual
burden hours
2,017
148
2,301
230
1,214
7,260
5,615
96
1,442
2,618
180
621
1,185
239
3,079
609
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Oncology.
Date: July 20–21, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Dr., Rm. 4158, MSC 7806, Bethesda, MD
20892, 301 435 1256, biesj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Auditory Mechanisms.
Date: July 20–21, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD (Virtual
Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Topics in Virology.
Date: July 21, 2015
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 80, Number 116 (Wednesday, June 17, 2015)]
[Notices]
[Pages 34684-34685]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14902]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Population
Assessment of Tobacco and Health (PATH) Study--3rd Wave (NIDA)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH) has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on February 11, 2015, pages 7619-7620 and allowed 60-days for
public comment. One public comment was received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Institute on Drug Abuse (NIDA), National Institutes of Health
may not conduct or sponsor, and the respondent is not required to
respond to, an information collection that has been extended, revised,
or implemented on or after October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_Submission@omb.eop.gov or by fax to (202) 395-6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project, contact: Dr. Kevin P. Conway, Deputy Director,
Division of Epidemiology, Services, and Prevention Research, NIDA, NIH,
6001 Executive Boulevard, Room 5185, Rockville, MD 20852; or call non-
toll-free number (301) 443-8755 or Email your request, including your
address to: PATHprojectofficer@mail.nih.gov. Formal requests for
additional plans and instruments must be requested in writing.
Proposed Collection: Population Assessment of Tobacco and Health
(PATH) Study--Third Wave of Data Collection--0925-0664--Revision,
National Institute on Drug Abuse (NIDA), National Institutes of Health
(NIH), in partnership with the Food and Drug Administration (FDA).
Need and Use of Information Collection: This is a revision request
(OMB 0925-0664, expires 9/30/2016) for the Population Assessment of
Tobacco and Health (PATH) Study to conduct the third wave of data
collection. The PATH Study is a national longitudinal cohort study of
tobacco use behavior and health among the U.S. household population of
adults age 18 and older and youth ages 12 to 17. The Study conducts
annual interviews and collects biospecimens from adults to assess
within-person changes and between-person differences in tobacco-product
use behaviors and related health conditions over time. Its
longitudinal, population-based data will help to enhance the evidence
base that informs FDA's regulatory actions under the Family Smoking
Prevention and Control Act to protect the Nation's public health and
reduce its burden of tobacco-related morbidity and mortality.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 54,434.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form or activity name Type of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Adult Extended Interview..... Adults........... 25,444 1 1 25,444
Consent for Adult Extended Adults........... 2,046 1 4/60 136
Interview.
[[Page 34685]]
Adult Extended Interview Adults........... 1,780 1 68/60 2,017
(Aged-up).
Consent for Biological Adults........... 1,780 1 5/60 148
Samples.
Biospecimen Collection: Urine Adults........... 13,805 1 10/60 2,301
Biospecimen Collection: Blood Adults........... 765 1 18/60 230
Tobacco Use Form............. Adults........... 14,570 1 5/60 1,214
Follow-up/Tracking Adults........... 27,224 2 8/60 7,260
Participant Information Form
for Adults.
Youth Extended Interview..... Youth............ 9,625 1 35/60 5,615
Assent for Youth Extended Youth............ 1,923 1 3/60 96
Interview.
Youth Extended Interview Youth............ 1,923 1 45/60 1,442
(Aged-up).
Parent Interview............. Parents.......... 9,818 1 16/60 2,618
Parent Permission and Consent Parents.......... 2,161 1 5/60 180
for Parent Interview.
Parent Interview (Aged-up)... Parents.......... 1,961 1 19/60 621
Verification Interview....... Adults........... 35,564 1 2/60 1,185
Validation Interview......... Adults........... 3,579 1 4/60 239
Follow-up/Tracking Parents.......... 11,548 2 8/60 3,079
Participant Information Form
for Youth.
Follow-up/Tracking Parents.......... 2,282 2 8/60 609
Participant Information Form
for Sample Shadow Youth.
----------------------------------------------------------------------------------------------------------------
Dated: June 12, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015-14902 Filed 6-16-15; 8:45 am]
BILLING CODE 4140-01-P
